Kathrin Brockmann

Prof. Dr. Kathrin Brockmann is an Associated Investigator at the Hertie Institute for Clinical Brain Research and Senior Physician at the Department of Neurodegenerative Diseases, University Hospital Tübingen. Her research focuses on large-scale longitudinal studies to understand neurodegeneration phases, symptom progression, and pathway-specific therapies.

• Research Group Leader and Clinical Coordinator of the Neurobiobank
• Principal Investigator of four major research projects related to Parkinson’s disease

Her work emphasizes patient stratification via genetic architecture and biomarker discovery in patient biomaterials to enable cause-specific treatments. As Clinical Coordinator of the Neurobiobank Tübingen, she integrates clinical and biomarker research.

She leads projects including the MJFF-PPMI Study (prodromal/genetic cohorts), MJFF PRKN/PINK1 Consortium, GBA1 Consortium for Clinical Trials, and DZNE-DESCRIBE-PD (sporadic/GBA-PD/LRRK2-PD). She also serves as Deputy in clinical trials exploring pathway-based treatments for neurodegenerative diseases.